Condition
Bladder Cancer (BC)
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Not Yet Recruiting2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07524426Not ApplicableNot Yet RecruitingPrimary
Local Radiotherapy for Urinary Bladder Cancer in Patients Not Eligible for Curative Treatment
NCT07503795Not Yet RecruitingPrimary
Outcomes of Definitive Radiotherapy for Bladder Cancer
NCT07359235Phase 1RecruitingPrimary
Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC)
Showing all 3 trials